CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI Major infections after bypass surgery and stenting: an overlooked but fatal complication Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention Genotype-Guided Strategy for Oral P2Y12 Inhibitors

GuidelineJanuary 2019

JOURNAL:J Am Coll Cardiol. Article Link

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

CT January, LS Wann, H Calkins et al. Keywords: Anticoagulation Management; Arrhythmias and Clinical EP; Heart Failure and Cardiomyopathies; Invasive Cardiovascular Angiography and Intervention; Prevention; Valvular Heart Disease; Anticoagulation Management and Atrial Fibrillation; Implantable Devices; SCD/Ventricular Arrhythmias; Atrial Fibrillation/Supraventricular Arrhythmias; Novel Agents; Acute Heart Failure; Interventions and Structural Heart Disease

FULL TEXT PDF